Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Leveraging its integrated “design-synthesis-quality control” system, Creative Biolabs is overcoming bottlenecks in mRNA drug expression and in vivo stability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results